Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $131.4200 (-0.66%) ($131.4200 - $131.4200) on Thu. Nov. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.97% (three month average) | RSI | 53 | Latest Price | $131.4200(-0.66%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(29%) EWY(22%) SHY(21%) SIL(21%) GDX(20%) | Factors Impacting SGEN price | SGEN will decline at least -0.985% in a week (0% probabilities). VCSH(-9%) VXX(-8%) XME(-7%) UNG(-7%) EDOC(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.985% (StdDev 1.97%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $132.22(-0.61%) | 10 Day Moving Average | $131.98(-0.42%) | 20 Day Moving Average | $130.44(0.75%) | To recent high | -23.5% | To recent low | 3.8% | Market Cap | $22.849b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |